Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6950
-0.0285 (-3.94%)
At close: Oct 2, 2026, 4:00 PM EDT
0.7001
+0.0051 (0.73%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Aprea Therapeutics Employees
Aprea Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$648
Profits / Employee
-$1,538,408
Market Cap
8.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Senti Biosciences Holdings | 39 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| FibroBiologics | 15 |
| Purple Biotech | 10 |
| MetaVia | 8 |
| Traws Pharma | 7 |
APRE News
- 10 days ago - Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium - GlobeNewsWire
- 18 days ago - Aprea Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 22 days ago - Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - Aprea Therapeutics provides update on existing patent portfolio - TheFly
- 5 weeks ago - Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs - GlobeNewsWire
- 6 weeks ago - Aprea Therapeutics reports Q2 EPS (7c), consensus (22c) - TheFly
- 7 weeks ago - Aprea Therapeutics Announces Second Quarter 2026 Financial Results - GlobeNewsWire
- 7 weeks ago - Aprea Therapeutics Earnings release: Q2 2026 - Filings